Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children [Phase 3]
Phase 3 safety study results completed for combination vaccines Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY in child…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID [Phase 1]
A Phase 1 proof-of-concept study evaluating the immunogenicity and safety of a Hepatitis B vaccine delivered in the dermis using VAX-ID, spo…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine [Phase 3]
This clinical trial update describes a Phase 3 exploratory study of hepatitis B virus kinetics during telbivudine treatment. The study statu…
-
CLINICAL_TRIALS research · 2017-03-28Clinical Trial Update: Empowering Immigrants in the Greater Boston Area to Connect to HBV Care
This clinical trial update from Massachusetts General Hospital describes efforts to help immigrants in the Greater Boston area connect to he…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years [Phase 3]
Phase 3 trial comparing an adjuvanted Hepatitis B vaccine to a double dose of Engerix-B in adults on pre-dialysis or haemodialysis, aged 15 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054) [Phase 3]
Phase 3 clinical trial updating safety, tolerability, and immunogenicity of a recombinant Hepatitis B vaccine with an upgraded production pr…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) [Phase 2]
Phase 2 trial update reporting completion of a study on a modified-process Hepatitis B vaccine in healthy neonates.
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver [Phase 1, Phase 2]
Phase 1/2 trial investigating adefovir plus vaccination in liver transplant recipients without Hepatitis B who are core antibody positive; s…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults [Phase 4]
This Phase 4 study reports that the combined Hepatitis A and B vaccine is non-inferior to monovalent vaccines in adults.
-
CLINICAL_TRIALS withdrawal · 2017-03-06Clinical Trial Update: Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα [Phase 3]
A Phase 3 trial evaluating antiviral prophylaxis for HBsAg-positive or HBcAb-positive/HBsAb-negative patients starting anti-TNF therapy has …
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Immune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in Infants [Phase 3]
Phase 3 clinical trial update assessing immune memory and reactogenicity of the DTPw-HBV/Hib pentavalent vaccine in infants, including respo…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
A completed substudy within the ATN 024/025 trials examining genetic factors related to the Hepatitis B vaccine in individuals with HIV infe…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B [Phase 3]
A Phase 3 clinical trial comparing switching from lamivudine to telbivudine versus continuing lamivudine in adults with chronic hepatitis B …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis B [Phase 4]
Phase 4 trial evaluating the efficacy and safety of telbivudine 600 mg tablets in Chinese patients with chronic hepatitis B completed.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Pegasys for chronic hepatitis B has completed.
-
CLINICAL_TRIALS withdrawal · 2017-02-17Clinical Trial Update: A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B. [Phase 4]
A Phase 4 trial evaluating 48 vs 96 weeks of Pegasys (peginterferon alfa-2a) with or without entecavir in chronic hepatitis B was withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers [Phase 1]
Phase 1 safety and pharmacokinetic study of Hepalatide (L47) in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine [Phase 2]
This Phase 2 trial evaluated the feasibility of administering an acellular pertussis vaccine soon after birth, followed by a 3-dose primary …
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program [Phase 4]
Phase 4 expanded-access study of peginterferon alfa-2a in chronic hepatitis B has completed and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Off-therapy Response After Stopping Entecavir or Tenofovir
A clinical trial assessing the off-therapy response after stopping entecavir or tenofovir in chronic hepatitis B patients; current status is…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
A clinical trial update reports the durability of antiviral activity in chronic hepatitis B patients who achieved complete response in the L…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBV [Phase 3]
Phase 3 study of clevudine 30 mg once daily in HBeAg-negative chronic hepatitis B was terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201 [Phase 2]
A Phase 2 safety and efficacy study of retreatment with clevudine in chronic hepatitis B patients who previously received clevudine in L-FMA…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials [Phase 3]
Phase 3 safety and antiviral activity update for Clevudine in Hepatitis B patients who completed L-FMAU-301 or L-FMAU-302; the trial has bee…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBV [Phase 3]
Phase 3 safety and antiviral activity study of clevudine 30 mg once daily in patients with chronic hepatitis B. The trial status is terminat…